Targretin oral (bexarotene oral)

News alerts, weekly reports and conference planners

Company:

ReXceptor

Drug class:

Retinoid X receptor modulator

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

No biomarker	Cutaneous T-cell Lymphoma	No biomarker	Cutaneous T-cell Lymphoma	bexarotene oral Sensitive: A1 - Approval bexarotene oral Sensitive : A1	bexarotene oral Sensitive: A1 - Approval bexarotene oral Sensitive : A1
RAD51AP1 overexpression	Hepatocellular Cancer	RAD51AP1 overexpression	Hepatocellular Cancer	bexarotene oral Sensitive: C3 – Early Trials bexarotene oral Sensitive : C3	bexarotene oral Sensitive: C3 – Early Trials bexarotene oral Sensitive : C3

Associations
(2)